ALLA MAKSIMOVA: Open Payments
NPI 1912462961 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,305 in 61 payments from 14 companies in 2025. Trend: 2023 $58 · 2024 $444 · 2025 $2,305
Food & beverage: $2,305
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 12 | $402 |
| Amgen Inc. | 13 | $366 |
| ABBVIE INC. | 7 | $255 |
| Novo Nordisk Inc | 7 | $244 |
| AstraZeneca Pharmaceuticals LP | 2 | $238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $181 |
| Phathom Pharmaceuticals, Inc. | 2 | $156 |
| Exact Sciences Corporation | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| GlaxoSmithKline, LLC. | 3 | $93 |
Products named: IBSRELA, BREZTRI, Ozempic, KRYSTEXXA, JARDIANCE, VOQUEZNA, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
